Market access, pricing and evidence generation remain central issues for life sciences commercial strategy in Europe. World Epa Congress 2027 takes place from 2 to 3 March 2027 at the RAI International Exhibition and Congress Centre in Amsterdam and gathers market access, HEOR and payer stakeholders.
Dates and venue for World Epa Congress 2027
The event runs on 2 and 3 March 2027 at the RAI International Exhibition and Congress Centre. The venue hosts both the conference tracks and the exhibition area.
Who attends World Epa Congress 2027
Attendees include pharma and biotech market access teams, payer and HTA representatives, and solution providers for evidence generation. The speaker roster includes industry and academic leaders such as Jag Chhatwal, Yvette Venable and Sally Chung, representing HEOR, pricing and access functions.
Program highlights and speaker profile in Amsterdam
The congress features 10 thematic tracks addressing market access, pricing, reimbursement, rare diseases, HTA and health economics. The official program lists 250+ speakers delivering case-based presentations and technical sessions alongside exhibition-led demos focused on RWE and pricing tools.
Key figures for the congress
- Delegates 1600+
- Speakers 250+
- Exhibitors 120+
- Tracks 10
- Dates 2-3 March 2027
These figures underline the scope of the meeting and the concentration of market access expertise present in Amsterdam.
Preparing B2B prospecting at World Epa Congress 2027
Define target companies and therapeutic areas before travelling. Use the sponsors and floorplan to schedule one-to-one meetings with priority accounts, and prepare concise technical dossiers that link evidence generation to payer outcomes. Aim your pitch at measurable health economic endpoints and deployment pathways for pilots or local assessments.
Networking and commercial approach
Built-in networking sessions and the exhibition provide the setting for short decision-focused meetings. Book 20 to 30 minute slots with market access leads, and seek demonstrations from vendors that can integrate RWE into pricing strategies. When engaging payer or HTA participants concentrate on comparative value and reimbursement implications.
Closing note and action
For teams focused on pricing strategy and evidence that supports reimbursement, center your agenda on HEOR and HTA tracks and secure meetings with exhibitors offering RWE and economic modeling tools. Registration, agenda and sponsorship options are available at http://www.terrapinn.com/conference/pharma-pricing/index.stm; prepare technical materials that link outcomes to payer decision criteria.
Imágenes
